Optinose Announces Closing of $46.0 Million Public Offering of Common Stock Nov 18, 2021 02:00PM
OptiNose (OPTN) Prices 25M Share Offering at $1.60/sh Nov 16, 2021 08:02AM
Optinose Announces Pricing of Public Offering of Common Stock Nov 16, 2021 08:01AM
OptiNose (OPTN) Announces Proposed Public Offering of Common Stock Nov 15, 2021 05:41PM
Optinose Announces Proposed Public Offering of Common Stock Nov 15, 2021 05:40PM


Jun 30, 2020 11:48AM Cantor Fitzgerald Positive on Optinose (OPTN) Related to OPN-019 for COVID
Jun 16, 2020 07:04AM Companies with NDRs 6/16
Jun 15, 2020 07:21AM Companies with NDRs 6/15
Apr 28, 2020 01:09PM Optinose (OPTN) PT Lowered to $18 at Cantor Fitzgerald
Mar 5, 2020 12:18PM Optinose (OPTN) PT Lowered to $21 at Cantor Fitzgerald
Aug 7, 2018 04:08PM Cantor Fitzgerald Starts Optinose (OPTN) at Overweight
Aug 7, 2018 04:05PM Cantor Fitzgerald Starts Optinose (OPTN) at Overweight
Jan 2, 2018 08:00AM Optinose Announces $100 Million Debt Financing from Athyrium Capital Management
Jan 2, 2018 08:00AM Optinose Announces $100 Million Debt Financing from Athyrium Capital Management